Planforge Launches Broad Initiative for AI-Powered Project Work Management
Development Focuses on Practical Use Cases Based on Comprehensive Research and Collaborative Customer Feedback
AI is transforming the world of project management by offering solutions to complex problems. Yet, many project managers struggle to pinpoint AI applications that deliver tangible, practical value. Planforge, a leading provider of project work management software, is precisely addressing this challenge head-on.
The company’s new AI initiative focuses on identifying and developing features that offer practical support to project managers, specifically designed for standards-based project management in Europe. The first use cases are set to debut in the upcoming 2025 release, featuring AI-driven enhancements aimed at streamlining project planning processes and enabling managers to define clear objectives more efficiently. This initiative marks the beginning of Planforge’s long-term commitment to advancing AI-powered solutions for project management.
In-Depth Research and Real-World Use Cases
Building on 15 years of experience in project management, Planforge has conducted extensive research on how AI can deliver meaningful value. “We’ve seen many demonstrations of AI in project management that sound good in theory but fall short in practice,” says Gerald Aquila, CEO and founder of Planforge. “Our goal is to focus on real-world use cases that provide genuine benefits to project managers in their daily work and deliver true added value.”
Planforge analyzed over 30 core project management processes to identify how generative AI and large language models (LLMs) can be integrated to support project managers. Many of these use cases are ready for immediate deployment, while others remain aspirational as AI capabilities continue to evolve.
The Role of Customer Collaboration
Planforge prioritizes its AI roadmap in close collaboration with its customers, as their insights are crucial to the development process. At the recent annual Planforge Unite event, the team actively engaged with users to brainstorm ideas and AI-driven use cases, discuss challenges, and collect valuable feedback. This ongoing dialogue ensures that Planforge’s solutions remain relevant and effective, addressing the actual needs of users.
AI-Powered Use Cases for Project Management
As part of its commitment to enhancing user experience, Planforge plans to roll out AI-driven improvements step by step in selected use cases, following thorough testing in real-world environments. One of the key features slated for release in Planforge 25, is the automatic generation of project objectives based on project description, linked ideas, and additional metadata. This will help project managers and owners define clearer objectives, which may, in turn, support the planning process.
Availability
Planforge is free for up to four users. Larger teams can test the project work management software with a free 30-day trial. For more information or to be among the first to try the new AI-driven project management features, please contact the Planforge sales team at info@planforge.io.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211471094/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom